Mosaic Family Wealth’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
ACA
CC
Mosaic Family Wealth's SRPT Position: Q4 2021 in Review
Mosaic Family Wealth held its Sarepta Therapeutics (SRPT) position steady in Q4 2021 at 3,269 shares worth $294K. The position accounts for 0.08% of the portfolio, ranked #138.
Mosaic Family Wealth first reported a position in SRPT in Q4 2015 and has held it in 25 quarters since. The position peaked at $699K in Q4 2020. 344 funds tracked by Wall St. Rank hold SRPT as of Q4 2021.
- Mosaic Family Wealth held 3,269 shares of Sarepta Therapeutics worth $294K as of Q4 2021.
- Mosaic Family Wealth left its Sarepta Therapeutics share count unchanged in Q4 2021.
- Sarepta Therapeutics made up 0.08% of Mosaic Family Wealth's portfolio in Q4 2021, its #138 holding.
- Mosaic Family Wealth first reported a position in Sarepta Therapeutics in Q4 2015 and has held it in 25 quarters since.
- Mosaic Family Wealth's Sarepta Therapeutics position peaked at $699K in Q4 2020.
- 344 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2021.
Based on Mosaic Family Wealth's 13F filing for Q4 2021, filed 25 Jan 2022.